Microorganism-derived molecules as enzyme inhibitors to target Alzheimer's diseases pathways

TH Nguyen, SL Wang, VB Nguyen - Pharmaceuticals, 2023 - mdpi.com
Alzheimer's disease (AD) is the most common form of dementia. It increases the risk of other
serious diseases and causes a huge impact on individuals, families, and socioeconomics …

Therapeutics of Alzheimer's disease: Recent developments

S Burns, A Selman, U Sehar, P Rawat, AP Reddy… - Antioxidants, 2022 - mdpi.com
With increasing aging, dementia is a growing public health concern globally. Patients with
dementia have multiple psychological and behavioral changes, including depression …

Normalized group activations based feature extraction technique using heterogeneous data for Alzheimer's disease classification

K Vaithianathan, JB Pernabas, L Parthiban… - PeerJ Computer …, 2024 - peerj.com
Several deep learning networks are developed to identify the complex atrophic patterns of
Alzheimer's disease (AD). Among various activation functions used in deep neural networks …

Amelioration of Alzheimer's disease with extracts of Punica granatum and Persea americana in AlCl3 induced rats

AAEM Ali, SM El-Hallouty… - Egyptian Journal of …, 2023 - journals.ekb.eg
Background: Alzheimer's disease is a neurological disease that progresses over time. It is
defined by the presence of both extracellular amyloidbeta (Ab) plaques, which are primarily …